Jaguar health announces selection of investment bank and nominated advisor for proposed merger of the dragon spac and napo eu, jaguar's italian subsidiary

Update regarding march 15, 2021 meeting with european regulatory authority regarding potential covid-related indication for crofelemer san francisco, ca / accesswire / march 30, 2021 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company"), today announced that the company supports the selection of the investment bank and nominated advisor ("nomad") made by the lead sponsor of the planned dragon special purpose acquisition company (the "dragon spac"). the dragon spac anticipates listing on aim italia and merging with its named target, napo eu s.p.a.
JAGX Ratings Summary
JAGX Quant Ranking